|
|
|
Volumn 56, Issue 1, 2002, Pages 53-56
|
|
The MRC/BHF heart protection study: Preliminary results
a a a |
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA TOCOPHEROL;
ANTIOXIDANT;
ASCORBIC ACID;
BETA CAROTENE;
CHOLESTEROL;
CREATINE KINASE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LIVER ENZYME;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
PLACEBO;
SIMVASTATIN;
AGE;
AGED;
CHOLESTEROL BLOOD LEVEL;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIABETES MELLITUS;
DOUBLE BLIND PROCEDURE;
DRUG SAFETY;
DRUG TOLERABILITY;
FACTORIAL ANALYSIS;
FEMALE;
GENDER;
HEART MUSCLE REVASCULARIZATION;
HEART PROTECTION;
HIGH RISK PATIENT;
HUMAN;
ISCHEMIC HEART DISEASE;
LIVER EXAMINATION;
LIVER TOXICITY;
MAJOR CLINICAL STUDY;
MALE;
MEDICAL INFORMATION;
MORTALITY;
MYOPATHY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
STROKE;
WESTERN HEMISPHERE;
AGED;
ANTICHOLESTEREMIC AGENTS;
ANTIOXIDANTS;
ASCORBIC ACID;
BETA CAROTENE;
CORONARY DISEASE;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
PROSPECTIVE STUDIES;
SIMVASTATIN;
TREATMENT OUTCOME;
VITAMIN E;
|
|
EID: 0036156342
PISSN: 13685031
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (131)
|
|
References (6)
|
